share_log

北京市通商律师事务所关于华熙生物调整 2021年限制性股激励计划首次及预授价格、作废部分已授予尚未归属的限制性股票及首次授予部分第二个归属期及预留授予部分第一个归属期归属条件成就事项之法律意见书

Legal opinion of Beijing Trade Law Firm on Huaxi Biotech's adjustment of the initial and pre-order prices of the 2021 restricted stock incentive plan, the annulment portion of restricted shares that have not yet been granted, and the first grant of part of

深证信a股 ·  Mar 30, 2023 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more